Matthews International Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History

Matthews International Capital Management LLC

  • $468 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$19.5 - $31.26 $3.74 Million - $5.99 Million
-191,568 Closed
0 $0
Q2 2020

Jul 29, 2020
BUY
$25.68 - $38.12 $4.92 Million - $7.3 Million
191,568 New
191,568 $6.46 Million

Others Institutions Holding ORIC

# of Institutions
127
Shares Held
66.6M
Call Options Held
7.8K
Put Options Held
700
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $393M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Matthews International Capital Management LLC Portfolio

Follow Matthews International Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email